Description

Indapen SR Coated Tablets with Modified Release 1.5 mg. №30

Ingredients

Each tablet contains 1.5 mg of Indapamide.

Dosage

The recommended dosage is one tablet daily, preferably in the morning.

Indications

Indapen SR is indicated for the treatment of hypertension. It helps to lower blood pressure and reduce the risk of stroke and heart attacks.

Contraindications

Do not use Indapen SR if you are allergic to indapamide or if you have severe kidney disease. It is important to consult a healthcare provider before starting this medication.

Directions

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. It can be taken with or without food.

Scientific Evidence

Indapamide, the active ingredient in Indapen SR, is a thiazide-like diuretic that works by increasing the excretion of sodium and water, leading to decreased blood volume and lowered blood pressure. Studies have shown that long-term use of indapamide is effective in reducing blood pressure and preventing cardiovascular events. According to a meta-analysis published in the Journal of Hypertension, indapamide-based therapies were found to significantly reduce the risk of stroke and coronary events compared to placebo.

Additional Information

Indapen SR with modified release formulation ensures a sustained effect over 24 hours, providing continuous blood pressure control. It is well-tolerated by most patients with minimal side effects. However, like any medication, it may cause dizziness or electrolyte imbalances in some individuals. Regular monitoring of blood pressure and electrolyte levels is recommended during treatment with Indapen SR.

Indapen SR offers a convenient once-daily dosing regimen, improving patient adherence to treatment. Its efficacy and safety profile make it a valuable option in the management of hypertension. Consult your healthcare provider for personalized advice on the use of Indapen SR and to discuss any specific concerns or potential drug interactions.

Overall, Indapen SR coated tablets with modified release 1.5 mg. №30 provide an effective and well-established treatment option for individuals with hypertension. The medication’s mechanism of action, supported by scientific evidence and clinical trials, underscores its role in reducing cardiovascular risks and improving patient outcomes.